Although this study has a limited number of cases and used only IHC in paraffin-embedded tissue specimens, the results suggest that co-detection of mutant p53 and high NANOG levels in the pretreatment biopsy specimens of patients with OSCC is directly associated with unfavorable clinicopathological tumor features and poor survival rates. The gene discussed is TP53; the disease is neoplasm.